Conservatism, Consumer Choice, and the Food and Drug Administration During the Reagan Era: A Prescription for Scandal (2014)
In the last quarter of the 20th century, politicians in Washington, as well as interest groups, regulatory policy makers, and drug industry leaders were forced to confront the hot-button issue of pharmaceutical regulation. The struggle always centered on product innovation, consumer protection, and choice in the free market. As the American economy stuttered in the late 1970s, the stakes were extremely high for the powerful drug industry and the American public. At the center of this drama was the Food and Drug Administration, which was censured from both the left and right of the political spectrum for being too strict and too lenient in the application of its regulatory powers. Lucas Richert explores the FDA, drugs, and politics in the context of the watershed Reagan era, a period when the rhetoric of limited government, reduced regulation, and enhanced cooperation between businesses and U.S. regulatory agencies was on the ascent.As he investigates the controversies surrounding Laetrile, Reye’s Syndrome, Oraflex, patient package inserts, diet pills, and HIV/AIDS drugs, Richert argues that the practical application of conservative economic principles to the American drug industry was A Prescription for Scandal.
...MoreReview Wayne Hall (2016) Review of "Conservatism, Consumer Choice, and the Food and Drug Administration During the Reagan Era: A Prescription for Scandal". Social History of Medicine (pp. 202-203).
Review Christopher Cumo (2015) Review of "Conservatism, Consumer Choice, and the Food and Drug Administration During the Reagan Era: A Prescription for Scandal". Canadian Journal of History (pp. 184-185).
Similar Citations
Book
Horace A. Bartilow;
(2019)
Drug War Pathologies: Embedded Corporatism and U.S. Drug Enforcement in the Americas
(/p/isis/citation/CBB525075418/)
Book
Stark, Laura;
(2012)
Behind Closed Doors: IRBs and the Making of Ethical Reseach
(/p/isis/citation/CBB001221168/)
Book
Matthew R. Pembleton;
(2017)
Containing Addiction: The Federal Bureau of Narcotics and the Origins of America's Global Drug War
(/p/isis/citation/CBB917889933/)
Book
Nancy D. Campbell;
(2020)
OD: Naloxone and the Politics of Overdose
(/p/isis/citation/CBB601007525/)
Book
Stephen Snelders;
(2021)
Drug smuggler nation: Narcotics and the Netherlands, 1920–1995
(/p/isis/citation/CBB439238194/)
Article
Herzberg, David;
(2009)
“Will Wonder Drugs Never Cease!”: A Prehistory of Direct-to-Consumer Advertising
(/p/isis/citation/CBB000933443/)
Article
Enrico Cevolani;
(2016)
Un futuro per la canapa? Dall'alimentazione all'industria, il potenziale trascurato di una pianta straordinaria
(/p/isis/citation/CBB591727814/)
Article
Gwen Seabourne;
(2016)
Drugs, Deceit and Damage in Thirteenth-century Herefordshire: New Perspectives on Medieval Surgery, Sex and the Law
(/p/isis/citation/CBB679550995/)
Chapter
Swann, John P.;
(2005)
Pharmaceutical Regulation before and after the Food, Drug, and Cosmetic Act
(/p/isis/citation/CBB000500372/)
Article
Cooper, Dale;
(2007)
Why Campbell Crossed the Street: Consumers' Research Attempts to Instigate a Purge of the FDA
(/p/isis/citation/CBB000932012/)
Book
David A. Guba Jr;
(2020)
Taming Cannabis: Drugs and Empire in Nineteenth-Century France
(/p/isis/citation/CBB831549564/)
Article
Sismondo, Sergio;
(2004)
Pharmaceutical Maneuvers
(/p/isis/citation/CBB000651081/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/p/isis/citation/CBB001220743/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/p/isis/citation/CBB001214039/)
Article
Patricia Barton;
(2020)
“Who Takes the Blame?”: Retail Chemists, Doctors, and the Control of “Dangerous Drugs” in Inter-War Britain
(/p/isis/citation/CBB783230220/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2013)
Ways of Regulating Drugs in the 19th and 20th Centuries
(/p/isis/citation/CBB001252493/)
Article
Gaudillière, Jean-Paul;
(2005)
Introduction: Drug Trajectories
(/p/isis/citation/CBB000770705/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/p/isis/citation/CBB001221029/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/p/isis/citation/CBB001221032/)
Article
Thoms, Ulrike;
(2013)
Standardizing Selling. Pharmaceutical Marketing, the Pharmaceutical Company and the Marketing Expert (1900--1980)
(/p/isis/citation/CBB001320755/)
Be the first to comment!